HQIP / Resources / National Lung Cancer Audit – Annual Report 2018
National Lung Cancer Audit – Annual Report 2018
Published: 09 May 2019
This NLCA annual report represents the culmination of nearly 2 years of patient care and follow up, data collection, data analysis and interpretation. Its purpose is to understand the current quality of care and outcomes for patients with lung cancer, to celebrate good practice and to highlight variability, to ensure that all patients have access to the very best care.
The results published in this report demonstrate improving data quality, higher rates of surgical treatment, and higher rates of systemic anti-cancer treatment across both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), such that four out of our five key auditable measures have been achieved. Additionally, continuing improvements in data completeness can be observed with 85% completeness seen for performance status (PS), 96% for stage and 64% for recording of lung function in patients potentially suitable for curative treatment, as compared to 82%, 96% and 56% respectively in the previous reporting period.
Version 2 – amended report in February 2020 (pages 7 and 17: overall result for CNS changed from 70% to 71%, and for England from 70% to 72%, and seen by CNS at diagnosis changed from 58% to 60%).